[ MAIN NAVIGATION ]

[ SECONDARY NAVIGATION ]

Profiles

Awards Selected for Grant Funding - LSDF 2009 Project Grant Competition

LSDF proudly announces awardees for the 2009 Project grant competition. The funded studies will focus on promoting bone healing; optimizing limb amputation procedures; enhancing cancer treatment; facilitating the validation of biomarkers; generating a wheat variety that is safe for individuals with celiac disease; and developing novel cancer chemotherapeutics. Funding for these grants comes from Washington's allocation of bonus payments under the Master Tobacco Settlement, revenues arising from multi-state litigation with tobacco product manufacturers. This LSDF group of awardees is the fifth to be funded through the tobacco settlement mechanism.

Norman Karin
$1,022,867
A Cost-Effective Hydrogel-Growth Factor Complex to Improve Bone Healing
Battelle, Pacific Northwest Division

Daniel Leotta
$509,051
Imaging Oximetry of Peripheral Ischemia for Identification of Amputation Level
University of Washington

Andre Lieber
$202,759
Peptides that Increase the Efficacy of Monoclonal Antibody Therapy of Cancer
University of Washington

Daniel Martin
$700,871
High-Throughput Generation of Monoclonal Anti-Peptide Antibodies for High Sensitivity Targeted MS Analysis of Biomarker Candidates
Institute for Systems Biology

Tomikazu Sasaki
$1,491,136
Development of Artemisinin Compounds for Cancer Treatment
University of Washington

Diter von Wettstein
$1,099,998
Wheat for Celiac Patients and Improved Disease Prevention
Washington State University

All LSDF Grant Competition Awards

• LSDF 07-01 Project Grant Awardees
• LSDF 07-02 Program Grant Awardees
• LSDF 08-01 Project Grant Awardees
• LSDF 08-02 Program Grant Awardees
• LSDF 09-01 Project Grant Awardees
• LSDF 09-02 Program Grant Awardees
• LSDF 2009 Winter Commercialization Grant Awardees
• LSDF 2009 Summer Commercialization Grant Awardee
• LSDF 2009 Opportunity Grant Awardee
• LSDF 2010 Commercialization Grant Awardees